{
    "URL": "https://doi.org/10.1371/journal.pntd.0002790",
    "Published": "April 10, 2014",
    "Subject_Areas": [
        "Rift Valley fever virus",
        "Drug therapy",
        "Aerosols",
        "Antivirals",
        "Antiviral therapy",
        "Rift Valley fever",
        "Viral pathogens",
        "Respiratory infections"
    ],
    "Authors": {
        "Amy L. Caroline": [
            "Regional Biocontainment Laboratory, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America"
        ],
        "Diana S. Powell": [
            "Regional Biocontainment Laboratory, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America"
        ],
        "Laura M. Bethel": [
            "Regional Biocontainment Laboratory, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America"
        ],
        "Tim D. Oury": [
            "Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America"
        ],
        "Douglas S. Reed": [
            "Regional Biocontainment Laboratory, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America",
            "Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America"
        ],
        "Amy L. Hartman": [
            "Regional Biocontainment Laboratory, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America",
            "Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America"
        ]
    }
}